The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX(®) Recurrence Score in ER-Positive Invasive Breast Cancers

We assessed mRNA and protein expression levels of the ZN217 oncogene in 17 clinical FFPE ER-positive invasive breast cancer specimens with known (low or high) Oncotype DX(®) Recurrence Scores. This study shows that mRNA or nuclear protein levels of the ZNF217 significantly correlate with Oncotype DX...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Pascale A., Loudig, Olivier, Liu, Christina, Albanese, Joseph, Fineberg, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546897/
https://www.ncbi.nlm.nih.gov/pubmed/31191299
http://dx.doi.org/10.3389/fphar.2019.00524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546897/
https://www.ncbi.nlm.nih.gov/pubmed/31191299
http://dx.doi.org/10.3389/fphar.2019.00524

Ejemplares similares